Literature DB >> 8302123

Cytokines in experimental otitis media with effusion.

M D Johnson1, J E Fitzgerald, G Leonard, J A Burleson, D L Kreutzer.   

Abstract

Studies in the authors' laboratory have recently demonstrated the presence of potent inflammatory cytokines such as interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF alpha) in human middle ear effusions. The clinical significance of this finding has not been fully elucidated because of the limitations of human studies. We hypothesized that the chinchilla model of otitis media may be an appropriate system with which to study the role of cytokines in otitis media with effusion. To begin to investigate this possibility, 30 chinchillas underwent surgical blockage of the eustachian tube (ET) to promote effusion development. After 2 weeks, examination by otoscopy demonstrated 27 ears to have developed an effusion. Next, all middle ear clefts, in random manner, were either injected with heat-killed Streptococcus pneumoniae 1 x 10(6) in 0.1 mL normal saline, injected with 0.1 mL normal saline alone, or received no injection at all. Middle ear effusions were obtained and analyzed for IL-1 beta and TNF alpha by enzyme-linked immunosorbent assay (ELISA). This study demonstrated a significant correlation between IL-1 beta and the presence of an effusion (P < .001). Additionally, increased TNF alpha levels correlated with bacterial component presence (P < .001), i.e., mean TNF alpha level was 108, 10.8, and 0 pg/mL in bacteria, normal saline, and noninjected ears, respectively. These findings would suggest that cytokine expression may relate to specific pathological conditions and that the chinchilla model for otitis media with effusion (OME) could be used to further explore the role of cytokines in OME.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302123     DOI: 10.1288/00005537-199402000-00012

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Senthil Kumar K Sakthivel; Edwin W Ades; David E Briles; Susan K Hollingshead; James C Paton; Jacquelyn S Sampson; James W Lillard
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.

Authors:  A Sabirov; S Kodama; T Hirano; M Suzuki; G Mogi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.

Authors:  K Sato; C L Liebeler; M K Quartey; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-16       Impact factor: 2.503

5.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

6.  Effect of Ginkgo leaf parenteral solution on blood and cochlea antioxidant and immunity indexes in OM rats.

Authors:  Jiandong Zhao; Yu Su; Aiting Chen; Hu Yuan; Liangfa Liu; Wenming Wu
Journal:  Molecules       Date:  2011-12-15       Impact factor: 4.411

7.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.